img

Global and United States Biologics Monoclonal Antibodies Drug Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Biologics Monoclonal Antibodies Drug Market Report & Forecast 2024-2034

Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
Market Analysis and InsightsGlobal and United States Biologics Monoclonal Antibodies Drug Market
This report focuses on global and United States Biologics Monoclonal Antibodies Drug market, also covers the segmentation data of other regions in regional level and county level.
The global Biologics Monoclonal Antibodies Drug revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the review period (2024-2034).
In United States the Biologics Monoclonal Antibodies Drug revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of Biologics Monoclonal Antibodies Drug include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis and Merck, etc. The global five biggest players hold a share of % in 2024.
Global Biologics Monoclonal Antibodies Drug Scope and Market Size
Biologics Monoclonal Antibodies Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Biologics Monoclonal Antibodies Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the Biologics Monoclonal Antibodies Drug market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Eli Lilly
Novartis
Merck
Biogen
Sobi
Innovent Biologics
Segment by Type
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other

Segment by Application


Cancer
Autoimmune Disease
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Biologics Monoclonal Antibodies Drug definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Biologics Monoclonal Antibodies Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Biologics Monoclonal Antibodies Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Monoclonal Antibodies Drug revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Biologics Monoclonal Antibodies Drug Product Introduction
1.2 Global Biologics Monoclonal Antibodies Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global Biologics Monoclonal Antibodies Drug Market Size for the Year 2018-2034
1.2.2 United States Biologics Monoclonal Antibodies Drug Market Size for the Year 2018-2034
1.3 Biologics Monoclonal Antibodies Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States Biologics Monoclonal Antibodies Drug in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Biologics Monoclonal Antibodies Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 Biologics Monoclonal Antibodies Drug Market Dynamics
1.4.1 Biologics Monoclonal Antibodies Drug Industry Trends
1.4.2 Biologics Monoclonal Antibodies Drug Market Drivers
1.4.3 Biologics Monoclonal Antibodies Drug Market Challenges
1.4.4 Biologics Monoclonal Antibodies Drug Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Biologics Monoclonal Antibodies Drug by Type
2.1 Biologics Monoclonal Antibodies Drug Market Segment by Type
2.1.1 Infliximab
2.1.2 Rituximab
2.1.3 Trastuzumab
2.1.4 Adalimumab
2.1.5 Other
2.2 Global Biologics Monoclonal Antibodies Drug Market Size by Type (2018, 2024 & 2034)
2.3 Global Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2034)
2.4 United States Biologics Monoclonal Antibodies Drug Market Size by Type (2018, 2024 & 2034)
2.5 United States Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2034)
3 Biologics Monoclonal Antibodies Drug by Application
3.1 Biologics Monoclonal Antibodies Drug Market Segment by Application
3.1.1 Cancer
3.1.2 Autoimmune Disease
3.1.3 Other
3.2 Global Biologics Monoclonal Antibodies Drug Market Size by Application (2018, 2024 & 2034)
3.3 Global Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2034)
3.4 United States Biologics Monoclonal Antibodies Drug Market Size by Application (2018, 2024 & 2034)
3.5 United States Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2034)
4 Global Biologics Monoclonal Antibodies Drug Competitor Landscape by Company
4.1 Global Biologics Monoclonal Antibodies Drug Market Size by Company
4.1.1 Global Key Companies of Biologics Monoclonal Antibodies Drug, Ranked by Revenue (2024)
4.1.2 Global Biologics Monoclonal Antibodies Drug Revenue by Player (2018-2023)
4.2 Global Biologics Monoclonal Antibodies Drug Concentration Ratio (CR)
4.2.1 Biologics Monoclonal Antibodies Drug Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Biologics Monoclonal Antibodies Drug in 2024
4.2.3 Global Biologics Monoclonal Antibodies Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Biologics Monoclonal Antibodies Drug Head office and Area Served
4.4 Global Key Players of Biologics Monoclonal Antibodies Drug, Product and Application
4.5 Global Key Players of Biologics Monoclonal Antibodies Drug, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Biologics Monoclonal Antibodies Drug Market Size by Company
4.7.1 Key Players of Biologics Monoclonal Antibodies Drug in United States, Ranked by Revenue (2024)
4.7.2 United States Biologics Monoclonal Antibodies Drug Revenue by Players (2021, 2024 & 2023)
5 Global Biologics Monoclonal Antibodies Drug Market Size by Region
5.1 Global Biologics Monoclonal Antibodies Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Biologics Monoclonal Antibodies Drug Market Size by Region (2018-2034)
5.2.1 Global Biologics Monoclonal Antibodies Drug Market Size by Region: 2018-2023
5.2.2 Global Biologics Monoclonal Antibodies Drug Market Size by Region (2024-2034)
6 Americas
6.1 Americas Biologics Monoclonal Antibodies Drug Market Size YoY Growth 2018-2034
6.2 Americas Biologics Monoclonal Antibodies Drug Market Size by Type
6.2.1 Americas Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023)
6.2.2 Americas Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2034)
6.2.3 Americas Biologics Monoclonal Antibodies Drug Market Share by Type (2018-2034)
6.3 Americas Biologics Monoclonal Antibodies Drug Market Size by Application
6.3.1 Americas Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023)
6.3.2 Americas Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2034)
6.3.3 Americas Biologics Monoclonal Antibodies Drug Market Share by Application (2018-2034)
6.4 Americas Biologics Monoclonal Antibodies Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Biologics Monoclonal Antibodies Drug Market Size YoY Growth 2018-2034
7.2 EMEA Biologics Monoclonal Antibodies Drug Market Size by Type
7.2.1 EMEA Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023)
7.2.2 EMEA Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2034)
7.2.3 EMEA Biologics Monoclonal Antibodies Drug Market Share by Type (2018-2034)
7.3 EMEA Biologics Monoclonal Antibodies Drug Market Size by Application
7.3.1 EMEA Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023)
7.3.2 EMEA Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2034)
7.3.3 EMEA Biologics Monoclonal Antibodies Drug Market Share by Application (2018-2034)
7.4 EMEA Biologics Monoclonal Antibodies Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Biologics Monoclonal Antibodies Drug Market Size YoY Growth 2018-2034
8.2 China Biologics Monoclonal Antibodies Drug Market Size by Type
8.2.1 China Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023)
8.2.2 China Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2034)
8.2.3 China Biologics Monoclonal Antibodies Drug Market Share by Type (2018-2034)
8.3 China Biologics Monoclonal Antibodies Drug Market Size by Application
8.3.1 China Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023)
8.3.2 China Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2034)
8.3.3 China Biologics Monoclonal Antibodies Drug Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Biologics Monoclonal Antibodies Drug Market Size YoY Growth 2018-2034
9.2 APAC Biologics Monoclonal Antibodies Drug Market Size by Type
9.2.1 APAC Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023)
9.2.2 APAC Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2034)
9.2.3 APAC Biologics Monoclonal Antibodies Drug Market Share by Type (2018-2034)
9.3 APAC Biologics Monoclonal Antibodies Drug Market Size by Application
9.3.1 APAC Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023)
9.3.2 APAC Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2034)
9.3.3 APAC Biologics Monoclonal Antibodies Drug Market Share by Application (2018-2034)
9.4 APAC Biologics Monoclonal Antibodies Drug Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Roche
10.1.1 Roche Company Details
10.1.2 Roche Business Overview
10.1.3 Roche Biologics Monoclonal Antibodies Drug Introduction
10.1.4 Roche Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.1.5 Roche Recent Development
10.2 Amgen
10.2.1 Amgen Company Details
10.2.2 Amgen Business Overview
10.2.3 Amgen Biologics Monoclonal Antibodies Drug Introduction
10.2.4 Amgen Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.2.5 Amgen Recent Development
10.3 AbbVie
10.3.1 AbbVie Company Details
10.3.2 AbbVie Business Overview
10.3.3 AbbVie Biologics Monoclonal Antibodies Drug Introduction
10.3.4 AbbVie Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.3.5 AbbVie Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Details
10.4.2 Sanofi Business Overview
10.4.3 Sanofi Biologics Monoclonal Antibodies Drug Introduction
10.4.4 Sanofi Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.4.5 Sanofi Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Details
10.5.2 Johnson & Johnson Business Overview
10.5.3 Johnson & Johnson Biologics Monoclonal Antibodies Drug Introduction
10.5.4 Johnson & Johnson Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.5.5 Johnson & Johnson Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Details
10.6.2 Pfizer Business Overview
10.6.3 Pfizer Biologics Monoclonal Antibodies Drug Introduction
10.6.4 Pfizer Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.6.5 Pfizer Recent Development
10.7 Eli Lilly
10.7.1 Eli Lilly Company Details
10.7.2 Eli Lilly Business Overview
10.7.3 Eli Lilly Biologics Monoclonal Antibodies Drug Introduction
10.7.4 Eli Lilly Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.7.5 Eli Lilly Recent Development
10.8 Novartis
10.8.1 Novartis Company Details
10.8.2 Novartis Business Overview
10.8.3 Novartis Biologics Monoclonal Antibodies Drug Introduction
10.8.4 Novartis Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.8.5 Novartis Recent Development
10.9 Merck
10.9.1 Merck Company Details
10.9.2 Merck Business Overview
10.9.3 Merck Biologics Monoclonal Antibodies Drug Introduction
10.9.4 Merck Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.9.5 Merck Recent Development
10.10 Biogen
10.10.1 Biogen Company Details
10.10.2 Biogen Business Overview
10.10.3 Biogen Biologics Monoclonal Antibodies Drug Introduction
10.10.4 Biogen Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.10.5 Biogen Recent Development
10.11 Sobi
10.11.1 Sobi Company Details
10.11.2 Sobi Business Overview
10.11.3 Sobi Biologics Monoclonal Antibodies Drug Introduction
10.11.4 Sobi Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.11.5 Sobi Recent Development
10.12 Innovent Biologics
10.12.1 Innovent Biologics Company Details
10.12.2 Innovent Biologics Business Overview
10.12.3 Innovent Biologics Biologics Monoclonal Antibodies Drug Introduction
10.12.4 Innovent Biologics Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023)
10.12.5 Innovent Biologics Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Biologics Monoclonal Antibodies Drug Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Biologics Monoclonal Antibodies Drug Market Trends
Table 3. Biologics Monoclonal Antibodies Drug Market Drivers
Table 4. Biologics Monoclonal Antibodies Drug Market Challenges
Table 5. Biologics Monoclonal Antibodies Drug Market Restraints
Table 6. Global Biologics Monoclonal Antibodies Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Biologics Monoclonal Antibodies Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Biologics Monoclonal Antibodies Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Biologics Monoclonal Antibodies Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Biologics Monoclonal Antibodies Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Biologics Monoclonal Antibodies Drug Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Biologics Monoclonal Antibodies Drug Revenue Share by Player, 2018-2023
Table 13. Global Biologics Monoclonal Antibodies Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biologics Monoclonal Antibodies Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Monoclonal Antibodies Drug as of 2024)
Table 15. Global Key Players of Biologics Monoclonal Antibodies Drug, Headquarters and Area Served
Table 16. Global Key Players of Biologics Monoclonal Antibodies Drug, Product and Application
Table 17. Global Key Players of Biologics Monoclonal Antibodies Drug, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Biologics Monoclonal Antibodies Drug in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States Biologics Monoclonal Antibodies Drug Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States Biologics Monoclonal Antibodies Drug Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Biologics Monoclonal Antibodies Drug Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Biologics Monoclonal Antibodies Drug Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Biologics Monoclonal Antibodies Drug Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Biologics Monoclonal Antibodies Drug Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Biologics Monoclonal Antibodies Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Biologics Monoclonal Antibodies Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Biologics Monoclonal Antibodies Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Biologics Monoclonal Antibodies Drug Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Biologics Monoclonal Antibodies Drug Market Size by Region (2024-2034) & (US$ Million)
Table 51. Roche Company Details
Table 52. Roche Business Overview
Table 53. Roche Biologics Monoclonal Antibodies Drug Product
Table 54. Roche Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Amgen Company Details
Table 57. Amgen Business Overview
Table 58. Amgen Biologics Monoclonal Antibodies Drug Product
Table 59. Amgen Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 60. Amgen Recent Development
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Biologics Monoclonal Antibodies Drug Product
Table 64. AbbVie Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Biologics Monoclonal Antibodies Drug Product
Table 69. Sanofi Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Biologics Monoclonal Antibodies Drug Product
Table 74. Johnson & Johnson Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Biologics Monoclonal Antibodies Drug Product
Table 79. Pfizer Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Eli Lilly Company Details
Table 82. Eli Lilly Business Overview
Table 83. Eli Lilly Biologics Monoclonal Antibodies Drug Product
Table 84. Eli Lilly Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 85. Eli Lilly Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Biologics Monoclonal Antibodies Drug Product
Table 89. Novartis Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Biologics Monoclonal Antibodies Drug Product
Table 94. Merck Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Biogen Company Details
Table 97. Biogen Business Overview
Table 98. Biogen Biologics Monoclonal Antibodies Drug Product
Table 99. Biogen Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 100. Biogen Recent Development
Table 101. Sobi Company Details
Table 102. Sobi Business Overview
Table 103. Sobi Biologics Monoclonal Antibodies Drug Product
Table 104. Sobi Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 105. Sobi Recent Development
Table 106. Innovent Biologics Company Details
Table 107. Innovent Biologics Business Overview
Table 108. Innovent Biologics Biologics Monoclonal Antibodies Drug Product
Table 109. Innovent Biologics Revenue in Biologics Monoclonal Antibodies Drug Business (2018-2023) & (US$ Million)
Table 110. Innovent Biologics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics Monoclonal Antibodies Drug Product Picture
Figure 2. Global Biologics Monoclonal Antibodies Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Biologics Monoclonal Antibodies Drug Market Size 2018-2034 (US$ Million)
Figure 4. United States Biologics Monoclonal Antibodies Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States Biologics Monoclonal Antibodies Drug Market Size 2018-2034 (US$ Million)
Figure 6. United States Biologics Monoclonal Antibodies Drug Market Share in Global 2018-2034
Figure 7. Biologics Monoclonal Antibodies Drug Report Years Considered
Figure 8. Product Picture of Infliximab
Figure 9. Product Picture of Rituximab
Figure 10. Product Picture of Trastuzumab
Figure 11. Product Picture of Adalimumab
Figure 12. Product Picture of Other
Figure 13. Global Biologics Monoclonal Antibodies Drug Market Share by Type in 2024 & 2034
Figure 14. Global Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 15. Global Biologics Monoclonal Antibodies Drug Market Share by Type (2018-2034)
Figure 16. United States Biologics Monoclonal Antibodies Drug Market Share by Type in 2024 & 2034
Figure 17. United States Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 18. United States Biologics Monoclonal Antibodies Drug Market Share by Type (2018-2034)
Figure 19. Product Picture of Cancer
Figure 20. Product Picture of Autoimmune Disease
Figure 21. Product Picture of Other
Figure 22. Global Biologics Monoclonal Antibodies Drug Market Share by Application in 2024 & 2034
Figure 23. Global Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 24. Global Biologics Monoclonal Antibodies Drug Market Share by Application (2018-2034)
Figure 25. United States Biologics Monoclonal Antibodies Drug Market Share by Application in 2024 & 2034
Figure 26. United States Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 27. United States Biologics Monoclonal Antibodies Drug Market Share by Application (2018-2034)
Figure 28. The Top 5 and 10 Largest Companies of Biologics Monoclonal Antibodies Drug in the World: Market Share by Biologics Monoclonal Antibodies Drug Revenue in 2024
Figure 29. Global Biologics Monoclonal Antibodies Drug Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 30. Global Biologics Monoclonal Antibodies Drug Market Share by Region (2018-2034)
Figure 31. Americas Biologics Monoclonal Antibodies Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 32. Americas Biologics Monoclonal Antibodies Drug Market Share by Type (2018-2034)
Figure 33. Americas Biologics Monoclonal Antibodies Drug Market Share by Application (2018-2034)
Figure 34. United States Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. Canada Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 36. Mexico Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 37. Brazil Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 38. EMEA Biologics Monoclonal Antibodies Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 39. EMEA Biologics Monoclonal Antibodies Drug Market Share by Type (2018-2034)
Figure 40. EMEA Biologics Monoclonal Antibodies Drug Market Share by Application (2018-2034)
Figure 41. Europe Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 42. Middle East Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 43. Africa Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 44. China Biologics Monoclonal Antibodies Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 45. China Biologics Monoclonal Antibodies Drug Market Share by Type (2018-2034)
Figure 46. China Biologics Monoclonal Antibodies Drug Market Share by Application (2018-2034)
Figure 47. APAC Biologics Monoclonal Antibodies Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 48. APAC Biologics Monoclonal Antibodies Drug Market Share by Type (2018-2034)
Figure 49. APAC Biologics Monoclonal Antibodies Drug Market Share by Application (2018-2034)
Figure 50. Japan Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. South Korea Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. China Taiwan Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 53. Southeast Asia Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 54. India Biologics Monoclonal Antibodies Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 55. Roche Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 56. Amgen Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 57. AbbVie Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 58. Sanofi Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 59. Johnson & Johnson Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 60. Pfizer Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 61. Eli Lilly Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 62. Novartis Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 63. Merck Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 64. Biogen Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 65. Sobi Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 66. Innovent Biologics Revenue Growth Rate in Biologics Monoclonal Antibodies Drug Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries